1283 related articles for article (PubMed ID: 29343286)
1. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
[TBL] [Abstract][Full Text] [Related]
2. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
[TBL] [Abstract][Full Text] [Related]
3. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
5. Hereditary transthyretin-related amyloidosis.
Finsterer J; Iglseder S; Wanschitz J; Topakian R; Löscher WN; Grisold W
Acta Neurol Scand; 2019 Feb; 139(2):92-105. PubMed ID: 30295933
[TBL] [Abstract][Full Text] [Related]
6. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
[TBL] [Abstract][Full Text] [Related]
7. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy].
Sekijima Y
Rinsho Shinkeigaku; 2014; 54(12):953-6. PubMed ID: 25672679
[TBL] [Abstract][Full Text] [Related]
8. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
[TBL] [Abstract][Full Text] [Related]
9. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S
J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan.
Ikeda S; Takei Y; Tokuda T; Nakazato M; Ando Y
Amyloid; 2003 Aug; 10 Suppl 1():39-47. PubMed ID: 14640041
[TBL] [Abstract][Full Text] [Related]
11. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
[TBL] [Abstract][Full Text] [Related]
12. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
Vollmar J; Schmid JC; Hoppe-Lotichius M; Barreiros AP; Azizi M; Emrich T; Geber C; Schad A; Weyer V; Otto G; Heise M; Mittler J; Birklein F; Lang H; Galle PR; Zimmermann T
Transpl Int; 2018 Nov; 31(11):1207-1215. PubMed ID: 30091268
[TBL] [Abstract][Full Text] [Related]
13. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of familial amyloid polyneuropathy].
Adams D; Samuel D; Slama M
Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949
[TBL] [Abstract][Full Text] [Related]
15. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
16. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
[TBL] [Abstract][Full Text] [Related]
17. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
18. [Two elderly cases of transthyretin amyloid polyneuropathy without a family history].
Nomura T; Oshima Y; Yoshino M; Matsushima M; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2020 Oct; 60(10):688-692. PubMed ID: 32893242
[TBL] [Abstract][Full Text] [Related]
19. Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy.
Lamb YN; Deeks ED
Drugs; 2019 Jun; 79(8):863-874. PubMed ID: 31098895
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
